申请人:NIPPON CHEMIPHAR CO., LTD.
公开号:EP0584588A1
公开(公告)日:1994-03-02
Disclosed is an anti-ulcer composition to be dissolved in stomach to become directly into contact with walls of the stomach which comprises 100 weight parts of an imidazole derivative of the formula:
wherein each of R¹ and R² is hydrogen, substituted or unsubstituted alkyl, alkoxyalkyl, cycloalkyl, aryl, aralkyl, or R¹ and R² are combined to form hetero ring; each of R³, R⁴, R⁵ and R⁶ is hydrogen, halogen, substituted or unsubstituted alkoxy, substituted or unsubstituted alkyl, aryl, aryloxy, alkoxycarbonyl, nitro, amino, acyl, or R³ is combined with R² to form heteroring; R⁷ is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted arylcarbonyl, or S-containing heteroring; and each of R⁸ and R⁹ is hydrogen, halogen, substituted or unsubstituted alkoxy, unsubstituted or substituted alkyl, alkoxycarbonyl, aralkyl, nitro, amino, acyl, substituted or unsubstituted aryl, or R⁸ and R⁹ are combined to form alkylene, and 50 - 2,000 weigt parts of a basic material.
揭示了一种抗溃疡组合物,可在胃中溶解,直接与胃壁接触,包括以下成分:100重量部分的一种咪唑衍生物,其化学式为:其中R¹和R²中的每一个是氢、取代或未取代的烷基、烷氧基烷基、环烷基、芳基、芳基烷基,或R¹和R²组合形成杂环;R³、R⁴、R⁵和R⁶中的每一个是氢、卤素、取代或未取代的烷氧基、取代或未取代的烷基、芳基、芳氧基、烷氧羰基、硝基、氨基、酰基,或R³与R²结合形成杂环;R⁷是氢、取代或未取代的烷基、取代或未取代的芳基、取代或未取代的芳基羰基,或含S的杂环;R⁸和R⁹中的每一个是氢、卤素、取代或未取代的烷氧基、未取代或取代的烷基、烷氧羰基、芳基烷基、硝基、氨基、酰基、取代或未取代的芳基,或R⁸和R⁹组合形成亚烷基,以及50-2,000重量部分的一种碱性物质。